Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Windtree Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for WINT.
You can purchase shares of Windtree Therapeutics (NASDAQ:WINT) through any online brokerage.
Other companies in Windtree Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO), Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR) and Synaptogenix (NASDAQ:SNPX).
Windtree Therapeutics has a consensus price target of $7.00.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.992 last updated May 2, 2025 at 5:54 PM EDT.
There are no upcoming dividends for Windtree Therapeutics.
Windtree Therapeutics’s Q4 earnings are confirmed for Friday, May 16, 2025.
There is no upcoming split for Windtree Therapeutics.
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.